1. The effect of core fucosylation-mediated regulation of multiple signaling pathways on lung pericyte activation and fibrosis
    Ying Sun et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
  2. Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms
    Rama Malaviya et al, 2020, Toxicology and Applied Pharmacology CrossRef
  3. Transplantation of decellularized and lyophilized amniotic membrane inhibits endometrial fibrosis by regulating connective tissue growth factor and tissue inhibitor of matrix metalloproteinase‑2
    Xing Chen et al, 2021, Experimental and Therapeutic Medicine CrossRef
  4. Lipopolysaccharide induces epithelial–mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway
    Y Qin et al, 2020, Human & Experimental Toxicology CrossRef
  5. Role of nuclear factor-kappa B in bleomycin induced pulmonary fibrosis and the probable alleviating role of ginsenoside: histological, immunohistochemical, and biochemical study
    Dalia Refaat El-Bassouny et al, 2021, Anatomy & Cell Biology CrossRef
  6. lncRNAPCAT29 inhibits pulmonary fibrosis via the TGF‑β1‑regulated RASAL1/ERK1/2 signal pathway
    Xiaoming Liu et al, 2018, Molecular Medicine Reports CrossRef
  7. The importance of interventional timing in the bleomycin model of pulmonary fibrosis
    Philipp Kolb et al, 2020, European Respiratory Journal CrossRef
  8. The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
    Yuling Wang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  9. Mechanisms of carbon nanotube‐induced pulmonary fibrosis: a physicochemical characteristic perspective
    Katherine S. Duke et al, 2018, WIREs Nanomedicine and Nanobiotechnology CrossRef
  10. Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
    Si-Nan Lin et al, 2022, Physiological Reviews CrossRef
  11. Association between tissue inhibitor of metalloproteinase (TIMP) genetic polymorphisms and primary ovarian insufficiency (POI)
    Hui Jeong An et al, 2019, Maturitas CrossRef
  12. COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells via Nrf2-Mediated Inhibition of TGF-β1/Smad Signaling
    Chen-Yu Zhang et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  13. Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play
    Lourdes Chuliá-Peris et al, 2022, International Journal of Molecular Sciences CrossRef
  14. Adipose-derived stem/stromal cells with heparin-enhanced anti-inflammatory and antifibrotic effects mitigate induced pulmonary fibrosis in mice
    Takashi Saito et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  15. Jinlian Xiaodu Decoction Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats
    Zhiqiang Wu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  16. Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome
    Matt S. Zinter et al, 2019, American Journal of Respiratory and Critical Care Medicine CrossRef